chr3-58530656-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_003500.4(ACOX2):c.820-18C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.415 in 1,607,502 control chromosomes in the GnomAD database, including 147,604 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.31 ( 9445 hom., cov: 34)
Exomes 𝑓: 0.43 ( 138159 hom. )
Consequence
ACOX2
NM_003500.4 intron
NM_003500.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.0880
Genes affected
ACOX2 (HGNC:120): (acyl-CoA oxidase 2) The product of this gene belongs to the acyl-CoA oxidase family. It encodes the branched-chain acyl-CoA oxidase which is involved in the degradation of long branched fatty acids and bile acid intermediates in peroxisomes. Deficiency of this enzyme results in the accumulation of branched fatty acids and bile acid intermediates, and may lead to Zellweger syndrome, severe cognitive disability, and death in children. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 3-58530656-G-A is Benign according to our data. Variant chr3-58530656-G-A is described in ClinVar as [Benign]. Clinvar id is 1667807.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.442 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACOX2 | NM_003500.4 | c.820-18C>T | intron_variant | ENST00000302819.10 | NP_003491.1 | |||
ACOX2 | XM_005265505.2 | c.820-18C>T | intron_variant | XP_005265562.1 | ||||
ACOX2 | XM_006713340.4 | c.526-18C>T | intron_variant | XP_006713403.1 | ||||
ACOX2 | XM_047449042.1 | c.1018-18C>T | intron_variant | XP_047304998.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACOX2 | ENST00000302819.10 | c.820-18C>T | intron_variant | 1 | NM_003500.4 | ENSP00000307697 | P1 | |||
ACOX2 | ENST00000459701.6 | c.778-18C>T | intron_variant | 5 | ENSP00000418562 | |||||
ACOX2 | ENST00000489472.1 | c.*47+595C>T | intron_variant, NMD_transcript_variant | 5 | ENSP00000418515 |
Frequencies
GnomAD3 genomes AF: 0.313 AC: 47664AN: 152104Hom.: 9442 Cov.: 34
GnomAD3 genomes
AF:
AC:
47664
AN:
152104
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.361 AC: 88016AN: 243814Hom.: 17500 AF XY: 0.369 AC XY: 48577AN XY: 131540
GnomAD3 exomes
AF:
AC:
88016
AN:
243814
Hom.:
AF XY:
AC XY:
48577
AN XY:
131540
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.426 AC: 619691AN: 1455280Hom.: 138159 Cov.: 41 AF XY: 0.425 AC XY: 307192AN XY: 723140
GnomAD4 exome
AF:
AC:
619691
AN:
1455280
Hom.:
Cov.:
41
AF XY:
AC XY:
307192
AN XY:
723140
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.313 AC: 47667AN: 152222Hom.: 9445 Cov.: 34 AF XY: 0.308 AC XY: 22944AN XY: 74412
GnomAD4 genome
AF:
AC:
47667
AN:
152222
Hom.:
Cov.:
34
AF XY:
AC XY:
22944
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
739
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at